La Jolla Pharmaceutical intends to price public offering of its stock

Sale of common stock to be conducted by bookrunning manager Jefferies

By Devika Patel

Knoxville, Tenn., July 22 – La Jolla Pharmaceutical Co. said it plans to price a public sale of common stock with a 30-day greenshoe.

Jefferies LLC is the bookrunning manager.

Proceeds will be used for general corporate purposes, clinical trials, general and administrative expenses, potential acquisitions and other strategic purposes.

La Jolla Pharmaceutical is a San Diego-based biotechnology company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.